VOYA Investment Management
BHVN

VOYA Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

VOYA Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,252
Closed -$3.67M – 2991
2022
Q3 		$3.67M Buy
24,252
+693
+3% +$103K ﹤0.01% 1075
2022
Q2 		$3.43M Sell
23,559
-46,743
-66% -$5.97M 0.01% 890
2022
Q1 		$8.34M Buy
70,302
+20,898
+42% +$2.61M 0.02% 683
2021
Q4 		$6.81M Sell
49,404
-82,875
-63% -$10.5M 0.01% 733
2021
Q3 		$18.4M Sell
132,279
-50,588
-28% -$6.32M 0.04% 358
2021
Q2 		$17.8M Sell
182,867
-27,273
-13% -$2.21M 0.03% 388
2021
Q1 		$14.4M Buy
210,140
+29,097
+16% +$2.35M 0.03% 453
2020
Q4 		$15.5M Sell
181,043
-24,395
-12% -$2.07M 0.03% 415
2020
Q3 		$13.4M Sell
205,438
-2,024
-1% -$133K 0.03% 440
2020
Q2 		$15.2M Sell
207,462
-87,196
-30% -$4.64M 0.04% 406
2020
Q1 		$10M Buy
294,658
+20,110
+7% +$920K 0.03% 485
2019
Q4 		$14.9M Sell
274,548
-139,032
-34% -$6.88M 0.03% 479
2019
Q3 		$17.3M Buy
413,580
+157,079
+61% +$6.64M 0.04% 429
2019
Q2 		$11.2M Buy
256,501
+244,175
+1,981% +$13.8M 0.02% 570
2019
Q1 		$634K Buy
12,326
+351
+3% +$15.2K ﹤0.01% 1637
2018
Q4 		$443K Sell
11,975
-260
-2% -$9.37K ﹤0.01% 1802
2018
Q3 		$459K Sell
12,235
-620
-5% -$22.8K ﹤0.01% 1890
2018
Q2 		$508K Sell
12,855
-602
-4% -$19.1K ﹤0.01% 1821
2018
Q1 		$347K Buy
+13,457
New +$402K ﹤0.01% 2022

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

VOYA Investment Management's BHVN Position: Q4 2022 in Review

VOYA Investment Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 24,252 shares — an estimated $3.67M sold.

VOYA Investment Management first reported a position in BHVN in Q1 2018 and held it in 19 quarters. The position peaked at $18.4M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • VOYA Investment Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • VOYA Investment Management sold 24,252 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3.67M.
  • VOYA Investment Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 19 quarters.
  • VOYA Investment Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $18.4M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on VOYA Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.